台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    96.1
  • 漲跌
    ▲0.9
  • 漲幅
    +0.95%
  • 成交量
    522
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 306人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-統一-新台中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-新台中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/130.297.09297.4096.30-1.81,370-0.13%
2025/01/09195.80696.8894.60-51,341-0.37%
2025/01/081101.5000.00103.0011,2990.08%
2025/01/061100.002100.50101.50-11,259-0.08%
2025/01/03297.150.197.8098.301.91,2400.15%
2025/01/02394.2300.0093.6031,2350.24%
2024/12/26292.7000.0092.5021,2250.16%
2024/12/25490.4300.0091.0041,2140.33%
2024/12/0600.00893.5093.30-81,180-0.68%
2024/12/02195.1000.0094.4011,1580.09%
2024/11/2900.00198.3097.50-11,136-0.09%
2024/11/26193.8000.0094.0011,0840.09%
2024/11/25194.5000.0093.8011,0790.09%
2024/11/220.196.0000.0093.800.11,0310.01%
2024/11/21196.7000.0096.2011,0210.10%
2024/11/20197.4000.0096.5011,0180.10%
2024/11/19196.60895.6096.00-71,015-0.69%
2024/11/152100.7500.0099.9029890.20%
2024/11/141103.509102.67101.50-8971-0.82%
2024/11/121100.0000.00104.0019160.11%
2024/11/083101.5000.00103.0038730.34%
2024/11/0613105.5413106.73102.5008260.00%
2024/11/0500.001107.00106.00-1782-0.13%
2024/11/044101.0020104.00100.00-16758-2.11%
2024/11/0122105.2000.00105.00227303.01%
2024/10/3000.001102.00102.00-1617-0.16%
2024/10/293100.5000.00100.5036040.50%
2024/10/24699.901100.9798.3054941.01%
2024/10/18087.4500.0086.8004500.00%
2024/10/0800.00091.4091.1005070.00%
2024/10/0400.00188.7088.70-1541-0.18%
2024/09/11082.6000.0082.1006560.00%
2024/09/10182.6000.0083.3016620.15%
2024/09/05082.0000.0082.1006890.00%
2024/08/1500.001084.1784.50-10745-1.34%
2024/08/1300.001484.6884.40-14772-1.81%
2024/08/09586.30587.3085.4007830.00%
2024/08/06081.9000.0080.8007830.00%
2024/07/26195.30195.9397.6007290.00%
2024/07/1700.00898.6398.20-8658-1.21%
2024/07/16298.7000.0097.0026580.30%
2024/07/12295.7000.0095.6026480.31%
2024/07/1100.00396.1095.20-3650-0.46%
2024/07/10196.6000.0096.6016580.15%
2024/07/05397.5000.0097.5036250.48%
2024/07/021099.0600.0097.80106231.60%
2024/07/01899.860101.00101.0086101.31%
2024/06/26297.0000.0097.6025760.35%
2024/06/24093.7000.0093.2005890.00%
2024/06/0700.00193.5094.50-1644-0.16%
2024/06/0400.00790.8690.80-7647-1.08%
2024/05/3100.00690.8790.60-6729-0.82%
2024/05/20197.5000.0096.9018650.12%
2024/05/15494.20495.4593.9009520.00%
2024/04/30093.9000.0093.7001,4250.00%
2024/04/19089.0000.0089.0001,5230.00%
2024/04/17192.5000.0092.6011,5410.06%
2024/04/16091.55192.6091.00-11,557-0.06%
2024/04/12197.50597.9097.10-41,579-0.25%
2024/04/11198.1000.0097.9011,6150.06%
2024/04/0800.005100.0099.10-51,770-0.28%
2024/03/282100.0000.0099.4021,8390.11%
2024/03/2700.00198.3099.70-11,828-0.05%
2024/03/251100.00299.20101.00-11,816-0.06%
2024/03/21195.7000.0096.0011,8270.05%
2024/03/19197.4000.0096.8011,8640.05%
2024/03/15092.8000.0093.2001,8630.00%
2024/03/1300.00193.7092.40-11,896-0.05%
2024/03/11195.4000.0095.1011,9040.05%
2024/03/08097.0600.0095.1001,9240.00%
2024/03/07196.6900.0099.3011,9300.05%
2024/03/06298.70199.5098.1011,9370.05%
2024/02/2600.001104.50104.50-11,990-0.05%
2024/02/201101.5000.00101.5012,0580.05%
2024/02/162102.752102.00102.0002,0960.00%
2024/02/152110.752112.00110.5002,0600.00%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章